Key Prognostic Factors Create a Composite Risk Score to Stratify Patients into High- and Low-Treatment Benefit Groups: A Multicenter, Retrospective Data Analysis of 84 Metastatic Colorectal Cancer Patients Treated with Regorafenib as Part of the CORRECT and CONSIGN Trials

MLA

Zöhrlaut, Linda Katharina, et al. “Key Prognostic Factors Create a Composite Risk Score to Stratify Patients into High- and Low-Treatment Benefit Groups: A Multicenter, Retrospective Data Analysis of 84 Metastatic Colorectal Cancer Patients Treated with Regorafenib as Part of the CORRECT and CONSIGN Trials.” Oncology Research & Treatment, vol. 46, no. 9, Sept. 2023, pp. 348–61. EBSCOhost, https://doi.org/10.1159/000531268.

APA

Zöhrlaut, L. K., Karthaus, M., Vehling-Kaiser, U., von Kunhardt, L., Stintzing, S., Heinemann, V., & von Einem, J. C. (2023). Key Prognostic Factors Create a Composite Risk Score to Stratify Patients into High- and Low-Treatment Benefit Groups: A Multicenter, Retrospective Data Analysis of 84 Metastatic Colorectal Cancer Patients Treated with Regorafenib as Part of the CORRECT and CONSIGN Trials. Oncology Research & Treatment, 46(9), 348–361. https://doi.org/10.1159/000531268

Chicago

Zöhrlaut, Linda Katharina, Meinolf Karthaus, Ursula Vehling-Kaiser, Lukas von Kunhardt, Sebastian Stintzing, Volker Heinemann, and Jobst C. von Einem. 2023. “Key Prognostic Factors Create a Composite Risk Score to Stratify Patients into High- and Low-Treatment Benefit Groups: A Multicenter, Retrospective Data Analysis of 84 Metastatic Colorectal Cancer Patients Treated with Regorafenib as Part of the CORRECT and CONSIGN Trials.” Oncology Research & Treatment 46 (9): 348–61. doi:10.1159/000531268.